Public Cannabis Company Revenue Tracker Provides Updates through April 16, 2018

The Public Cannabis Company Revenue Tracker, managed by New Cannabis Ventures, ranks the top revenue producing cannabis stocks that generate industry sales of more than $2.5 million per quarter (in USD). This data-driven, fact-based tracker will continually update based on new filings so that readers can stay up to date. Companies must file with the SEC or SEDAR to be considered for inclusion.

Fifteen companies currently qualify for inclusion, with six filing in U.S dollars and nine in the Canadian currency. Yesterday, Aphria (TSX: APH) (OTC: APHQF) reported its Fiscal 2018 Q3 results and maintained its fourth position for Canadian listed companies or companies that report in Canadian dollars. Revenue of C$10.27 million, which included one month of sales from recently acquired Broken Coast of approximately C$1.1 million, grew 101% from year-ago levels. The company reported positive EBITDA and generated C$155K in cash from operations. The analyst consensus for its Q4 is approximately C$15.3 million in revenue, which could move it into third place.

Last week, Kush Bottles (OTC: KSHB) moved to the top spot for companies listed in the U.S. or reporting in U.S. dollars. Sales of $10.36 million in the fiscal second quarter ending February 28th grew 249% from a year ago and included a full quarter of revenue from the CMP Wellness acquisition that took place at the end of April a year ago. For Q3, Cowen and Company analyst Vivien Azer, the sole analyst providing financial projections on the company, expects KSHB to report sales of $12.0 million in Q3 and $49.4 million for FY2018, which ends on August 31st. She projects FY19 sales of $84.9 million.

Over the balance of April, several companies will provide updates.  Golden Leaf Holdings (CSE: GLH) (OTC: GLDFF) will be reporting its Q4 financials before the end of the month. Namaste Technologies(CSE: N) (OTC: NXTTF) will report its FY18-Q2 financials by the end of the month. Based on analyst estimates, Organigram (TSXV: OGI) (OTC: OGRMF), which reports its FY18-Q2 by the end of the month, is likely to join the list. In May, several companies will be providing quarterly updates, including Aurora Cannabis (TSX: ACB) (OTC: ACBFF) and CannTrust (TSX: TRST) (OTC: CNTTF) in Canada and CV Sciences (OTC: CVSI),  GrowGeneration (OTC: GRWG), GW Pharma (NASDAQ: GWPH) and Terra Tech (OTC: TRTC) in the United States.

Visit the Public Cannabis Company Revenue Tracker to see the complete list of qualifying companies.

Exclusive article by Alan Brochstein, CFA
Alan Brochstein, CFA
Based in Houston, Alan leverages his experience as founder of online community 420 Investor, the first and still largest due diligence platform focused on the publicly-traded stocks in the cannabis industry. With his extensive network in the cannabis community, Alan continues to find new ways to connect the industry and facilitate its sustainable growth. At New Cannabis Ventures, he is responsible for content development and strategic alliances. Before shifting his focus to the cannabis industry in early 2013, Alan, who began his career on Wall Street in 1986, worked as an independent research analyst following over two decades in research and portfolio management. A prolific writer, with over 650 articles published since 2007 at Seeking Alpha, where he has 70,000 followers, Alan is a frequent speaker at industry conferences and a frequent source to the media, including the NY Times, the Wall Street Journal, Fox Business, and Bloomberg TV. Contact Alan: Twitter | Facebook | LinkedIn | Email

Get Our Sunday Newsletter